8 Einträge gefunden

1. Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial)

   1. Krauter, Jürgen
   2. Fiedler, Walter
   3. Schlenk, Richard F
   4. Paschka, Peter
   5. Thol, Felicitas
   6. Lübbert, Michael
   7. Wattad, Mohammed

   2018 - Forschungsinformationssystem des UKE
2. Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trial

   1. Paschka, Peter
   2. Schlenk, Richard F
   3. Weber, Daniela
   4. Benner, Axel
   5. Bullinger, Lars
   6. Heuser, Michael
   7. Gaidzik, Verena I

   2018 - Forschungsinformationssystem des UKE
3. The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemia

   1. Both, Anna
   2. Krauter, Jürgen
   3. Damm, Frederik
   4. Thol, Felicitas
   5. Göhring, Gudrun
   6. Heuser, Michael
   7. Ottmann, Oliver

   2017 - Forschungsinformationssystem des UKE
4. Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia.

   1. Thol, Felicitas
   2. Winschel, Claudia
   3. Sonntag, Ann-Kathrin
   4. Damm, Frederik
   5. Wagner, Katharina
   6. Chaturvedi, Anuhar
   7. Göhring, Gudrun

   2013 - Forschungsinformationssystem des UKE
5. Prognostic importance of histone methyltransferase MLL5 expression in acute myeloid leukemia.

   1. Damm, Frederik
   2. Oberacker, Tina
   3. Thol, Felicitas
   4. Surdziel, Ewa
   5. Wagner, Katharina
   6. Chaturvedi, Anuhar
   7. Morgan, Michael

   2011 - Forschungsinformationssystem des UKE
6. Integrative prognostic risk score in acute myeloid leukemia with normal karyotype.

   1. Damm, Frederik
   2. Heuser, Michael
   3. Morgan, Michael
   4. Wagner, Katharina
   5. Görlich, Kerstin
   6. Grosshennig, Anika
   7. Hamwi, Iyas

   2011 - Forschungsinformationssystem des UKE
7. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.

   1. Thol, Felicitas
   2. Damm, Frederik
   3. Lüdeking, Andrea
   4. Winschel, Claudia
   5. Wagner, Katharina
   6. Morgan, Michael
   7. Yun, Haiyang

   2011 - Forschungsinformationssystem des UKE
8. Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia.

   1. Thol, Felicitas
   2. Damm, Frederik
   3. Wagner, Katharina
   4. Göhring, Gudrun
   5. Schlegelberger, Brigitte
   6. Hoelzer, Dieter
   7. Lübbert, Michael

   2010 - Forschungsinformationssystem des UKE